AIMD Ainos Corporation Return on Sales by Gross Profit

Demand for portable tests for home and clinic use is currently growing rapidly. Ainos, Inc. utilizes unique AI-powered microfluidic chips, creating a significant technological barrier. Revenue growth is driven by telemedicine and the development of the "Artificial Nose" system. The gross profit margin demonstrates the long-term sustainability of the business, with this metric equal to -643.50, which helps determine the investment horizon.
Financial and market metric breakdowns for ainos.com (AIMD)

Gross margin reflects the share of profit after deducting direct production costs, allowing for an assessment of the efficiency of cost management and asset pricing power. By analyzing gross margin growth, an investor can see how the diversification of Ainos, Inc. (AIMD) through the creation of home tests and remote monitoring systems impacts profitability, determining the business's scaling potential or the risks of capital stagnation.